The December 31, 2021, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the companys year-end reporting date.

Account Title	Debits		Credits
Cash	46,340
Accounts receivable	31,250
Prepaid rent	5,000
Inventory	48,750
Equipment	110,000
Accumulated depreciation			33,000
Accounts payable			35,000
Salaries payable			0
Common stock			100,000
Retained earnings			32,500
Sales revenue			483,000
Cost of goods sold	289,800
Salaries expense	96,600
Rent expense	30,000
Depreciation expense	0
Utilities expense	19,320
Advertising expense	6,440
Totals	683,500		683,500

The following year-end adjusting entries are required:

1. Depreciation expense for the year on the equipment is $11,000.
2. Salaries at year-end should be accrued in the amount of $6,200.